
Mercy Infusion supports patients prescribed HyQvia through coordinated SCIG Therapy services designed to simplify ongoing treatment and improve therapy access.
Our team assists with insurance coordination, Home Infusion onboarding, therapy education, refill coordination, and ongoing patient support.
HyQvia is a subcutaneous immune globulin therapy prescribed for patients requiring ongoing immunoglobulin replacement therapy.
Mercy Infusion supports eligible patients prescribed HyQvia through coordinated SCIG Therapy and Home Infusion services.
HyQvia may be prescribed for patients managing:
HyQvia is commonly coordinated through Mercy Infusion’s Home Infusion program, allowing eligible patients to receive ongoing SCIG therapy at home.
Our team helps coordinate:
Clinical coordination through our Infusion Suite may also be utilized depending on physician direction and patient needs.
Mercy Infusion helps simplify long-term SCIG therapy management by assisting with:
Our team works closely with physicians, patients, and insurance providers throughout treatment.
Is HyQvia administered through Home Infusion?
Yes. HyQvia is commonly coordinated through Mercy Infusion’s Home Infusion program depending on physician direction.
Can Mercy Infusion assist with ongoing therapy coordination?
Yes. Mercy Infusion helps support therapy onboarding, refill coordination, insurance communication, and ongoing patient support throughout treatment.
If you’ve been prescribed HyQvia and are exploring Home Infusion options, Mercy Infusion is here to help.